3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Dermatologic
1
Conditions
Myelodysplastic Syndromes
175
Leukemia, Myeloid, Acute
157
Myeloproliferative Disorders
74
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
73
Precursor Cell Lymphoblastic Leukemia-Lymphoma
56
Primary Myelofibrosis
52
Leukemia, Myelomonocytic, Chronic
45
Lymphoma, Non-Hodgkin
39
Leukemia
28
Polycythemia Vera
25
Hodgkin Disease
25
Thrombocythemia, Essential
22
Myelodysplastic-Myeloproliferative Diseases
22
Multiple Myeloma
21
Leukemia, Lymphocytic, Chronic, B-Cell
20
Leukemia, Biphenotypic, Acute
19
Hematologic Neoplasms
19
Neoplasms
17
Anemia, Refractory, with Excess of Blasts
15
Leukemia, Myeloid, Chronic-Phase
14
Sarcoma
13
Histiocytosis, Langerhans-Cell
13
Glioma
13
Recurrence
12
Neuroblastoma
12
Hematologic Diseases
12
Wilms Tumor
11
Rhabdoid Tumor
11
Osteosarcoma
11
Neuroectodermal Tumors, Primitive, Peripheral
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lupus Erythematosus, Systemic
×
Myeloid
×
90 days
×
Clear all
NCT02450396
2026-03-27
EGR2
Assistance Publique - Hôpitaux de Paris
Withdrawn